The SGC catalyzes research in new areas of human biology and drug discovery by focusing explicitly on less well-studied areas of the human genome. The SGC accelerates research in these new areas by making all its research output available to the scientific community with no strings attached, and by creating an open collaborative network of scientists in hundreds of universities around the world and in eight global pharmaceutical companies.

Research

Structural Genomics Consortium

Aled Edwards

Max Morgan

Cheryl Arrowsmith

Michael Sundström

Timothy Willson

Stefan Knapp

Susan McCormick

The executive team at Structural Genomics Consortium has a long history of working in research and academia. Members have experience working at the National Research Council Canada, McGill University, and the University of Oxford. They also have experience in industry, having worked at M4K Pharma. This diverse range of experiences gives the team a well-rounded perspective on research and development.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Structural Genomics Consortium

Board of Directors

Leadership Team